TY - JOUR
T1 - Physical Activity Is Associated with Attenuated Disease Progression in Chronic Obstructive Pulmonary Disease
AU - Demeyer, Heleen
AU - Donaire-Gonzalez, David
AU - Gimeno-Santos, Elena
AU - Ramon, Maria A.
AU - De Battle, Jordi
AU - Benet, Marta
AU - Serra, Ignasi
AU - Guerra, Stefano
AU - Farrero, Eva
AU - Rodriguez, Esther
AU - Ferrer, Jaume
AU - Sauleda, Jaume
AU - Monso, Eduard
AU - Gea, Joaquim
AU - Rodriguez-Roisin, Roberto
AU - Agusti, Alvar
AU - Antó, Josep M.
AU - Garcia-Aymerich, Judith
N1 - Funding Information:
Dr. Agusti reports grants from GSK, grants and personal fees from AstraZeneca, grants and personal fees from Menarini, personal fees from Chiesi, personal fees from Boehringer-Ingelheim, outside the submitted work. Dr. Rodriguez-Roison reports personal fees from AstraZeneca, personal fees from Boehringer-Ingelheim, and personal fees from Pearl Therapeutics, during the conduct of the study, all related to COPD. Dr. Judith Garcia-Aymerich’s institution has received consulting and lecture fees from AstraZeneca (not related to this study); she has received lecture fees from Esteve and Chiesi (not related to this study). For the remaining authors, none were declared. The results of the present study do not constitute endorsement by ACSM, and have been presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation.
Publisher Copyright:
Copyright © 2018 by the American College of Sports Medicine.
PY - 2019/5/1
Y1 - 2019/5/1
N2 - Introduction: Chronic obstructive pulmonary disease (COPD) progression is variable and affects several disease domains, including decline in lung function, exercise capacity, muscle strength, and health status as well as changes in body composition. We aimed to assess the longitudinal association of physical activity (PA) with these a priori selected components of disease progression. Methods: We studied 114 COPD patients from the PAC-COPD cohort (94% male, mean [SD], 70 yr [8 yr] of age, 54 [16] forced expiratory volume in 1 s % predicted) at baseline and 2.6 yr (0.6 yr) later. Baseline PA was assessed by accelerometry. Multivariable general linear models were built to assess the association between PA and changes in lung function, functional exercise capacity, muscle strength, health status, and body composition. All models were adjusted for confounders and the respective baseline value of each measure. Results: Per each 1000 steps higher baseline PA, forced expiratory volume in 1 s declined 7 mL less (P < 0.01), forced vital capacity 9 mL less (P = 0.03) and carbon monoxide diffusing capacity 0.10 mL·min -1 ·mm Hg -1 less (P = 0.04), while the St George's Respiratory Questionnaire symptom domain deteriorated 0.4 points less (P = 0.03), per year follow-up. Physical activity was not associated with changes in functional exercise capacity, muscle strength, other domains of health status or body composition. Conclusions: Higher PA is associated with attenuated decline in lung function and reduced health status (symptoms domain) deterioration in moderate-to-very severe COPD patients.
AB - Introduction: Chronic obstructive pulmonary disease (COPD) progression is variable and affects several disease domains, including decline in lung function, exercise capacity, muscle strength, and health status as well as changes in body composition. We aimed to assess the longitudinal association of physical activity (PA) with these a priori selected components of disease progression. Methods: We studied 114 COPD patients from the PAC-COPD cohort (94% male, mean [SD], 70 yr [8 yr] of age, 54 [16] forced expiratory volume in 1 s % predicted) at baseline and 2.6 yr (0.6 yr) later. Baseline PA was assessed by accelerometry. Multivariable general linear models were built to assess the association between PA and changes in lung function, functional exercise capacity, muscle strength, health status, and body composition. All models were adjusted for confounders and the respective baseline value of each measure. Results: Per each 1000 steps higher baseline PA, forced expiratory volume in 1 s declined 7 mL less (P < 0.01), forced vital capacity 9 mL less (P = 0.03) and carbon monoxide diffusing capacity 0.10 mL·min -1 ·mm Hg -1 less (P = 0.04), while the St George's Respiratory Questionnaire symptom domain deteriorated 0.4 points less (P = 0.03), per year follow-up. Physical activity was not associated with changes in functional exercise capacity, muscle strength, other domains of health status or body composition. Conclusions: Higher PA is associated with attenuated decline in lung function and reduced health status (symptoms domain) deterioration in moderate-to-very severe COPD patients.
KW - EXERCISE CAPACITY
KW - HEALTH STATUS
KW - LONGITUDINAL ANALYSIS
KW - LUNG FUNCTION
KW - MUSCLE STRENGTH
UR - http://www.scopus.com/inward/record.url?scp=85064198220&partnerID=8YFLogxK
U2 - 10.1249/MSS.0000000000001859
DO - 10.1249/MSS.0000000000001859
M3 - Article
C2 - 30531289
AN - SCOPUS:85064198220
SN - 0195-9131
VL - 51
SP - 833
EP - 840
JO - Medicine and Science in Sports and Exercise
JF - Medicine and Science in Sports and Exercise
IS - 5
ER -